All LHID2000 | HBV | HCV | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cancer type | Events | Ratea | Events | Ratea | IRRb | (95 % CI) | Events | Ratea | IRRb | (95 % CI) |
Overall | 40213 | 36.59 | 1330 | 94.01 | 2.95 | (2.80–3.12)* | 1232 | 163.00 | 3.33 | (3.15–3.53) |
Brain cancer | 509 | 0.46 | 7 | 0.49 | 1.13 | (0.53–2.38) | 7 | 0.93 | 1.61 | (0.76–3.39) |
Head and neck cancer | 4079 | 3.71 | 66 | 4.67 | 1.23 | (0.97–1.57) | 48 | 6.35 | 1.43 | (1.08–1.90)* |
Thyroid gland cancer | 1138 | 1.04 | 24 | 1.70 | 1.78 | (1.19–2.67)* | 13 | 1.72 | 1.53 | (0.89–2.65) |
Esophageal cancer | 850 | 0.77 | 15 | 1.06 | 1.45 | (0.87–2.42) | 11 | 1.46 | 1.48 | (0.82–2.68) |
Stomach cancer | 2247 | 2.04 | 32 | 2.26 | 1.42 | (1.00–2.01)* | 37 | 4.90 | 1.78 | (1.28–2.46)* |
Colorectal cancer | 5890 | 5.36 | 104 | 7.35 | 1.69 | (1.39–2.05)* | 83 | 10.98 | 1.51 | (1.21–1.87)* |
Liver cancer | 5293 | 4.82 | 770 | 54.43 | 12.89 | (11.9–13.9)* | 782 | 103.46 | 16.26 | (15.1–17.5)* |
Gallbladder and extrahepatic bile duct cancer | 501 | 0.46 | 14 | 0.99 | 2.80 | (1.64–4.76)* | 18 | 2.38 | 3.81 | (2.38–6.10)* |
Pancreatic cancer | 684 | 0.62 | 19 | 1.34 | 2.73 | (1.73–4.31)* | 17 | 2.25 | 2.66 | (1.65–4.31)* |
Lung cancer | 4656 | 4.24 | 74 | 5.23 | 1.57 | (1.25–1.97)* | 69 | 9.13 | 1.61 | 1.27–2.04)* |
Kidney cancer | 1065 | 0.97 | 28 | 1.98 | 2.47 | (1.70–3.60)* | 17 | 2.25 | 1.71 | (1.06–2.76)* |
Bladder cancer | 1324 | 1.20 | 24 | 1.70 | 1.83 | (1.22–2.74)* | 24 | 3.18 | 1.98 | (1.33–2.97)* |
Uterine and corpus cancerc | 600 | 1.10 | 14 | 2.29 | 2.12 | (1.25–3.61)* | 11 | 2.98 | 2.17 | (1.19–3.93)* |
Cervical cancerc | 1877 | 3.43 | 10 | 1.64 | 0.51 | (0.27–0.95) | 11 | 2.98 | 0.62 | (0.34–1.12) |
Ovarian cancerc | 592 | 1.08 | 15 | 2.45 | 2.29 | (1.37–3.82)* | 8 | 2.16 | 1.67 | (0.83–3.35) |
Prostate cancerd | 1820 | 3.30 | 30 | 3.73 | 1.83 | (1.28–2.63)* | 24 | 6.21 | 1.55 | (1.04–2.32)* |
Breast cancerc | 4695 | 8.58 | 74 | 12.10 | 1.43 | (1.14–1.80)* | 46 | 12.45 | 1.17 | (0.87–1.56) |
Melanoma | 136 | 0.12 | 0 | -- | -- | -- | 2 | 0.26 | 1.58 | (0.39–6.37) |
Skin cancer | 619 | 0.56 | 15 | 1.06 | 2.44 | (1.46–4.08)* | 11 | 1.46 | 1.90 | (1.04–3.44)* |
Non-Hodgkin’s lymphoma | 738 | 0.67 | 22 | 1.56 | 2.58 | (1.69–3.94)* | 20 | 2.65 | 3.01 | (1.93–4.69)* |
Myeloma | 218 | 0.20 | 2 | 0.14 | 0.87 | (0.22–3.49) | 3 | 0.40 | 1.47 | (0.47–4.60) |
Leukemia | 682 | 0.62 | 15 | 1.06 | 1.82 | (1.09–3.04)* | 7 | 0.93 | 1.19 | (0.56–2.50) |